Therapeutic benefit of melatonin in refractory central serous chorioretinopathy

PURPOSE: To evaluate the efficacy and safety of melatonin for the treatment of chronic central serous chorioretinopathy (CSCR). METHODS: Prospective comparative case series. A total of 13 patients with chronic CSCR were treated for 1 month: 8 patients were treated orally with 3 mg melatonin t.i.d.,...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:Eye (Lond)
Autors principals: Gramajo, A L, Marquez, G E, Torres, V E, Juárez, C P, Rosenstein, R E, Luna, J D
Format: Artigo
Idioma:Inglês
Publicat: Nature Publishing Group 2015
Matèries:
Clinical Study
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC4541344/
https://ncbi.nlm.nih.gov/pubmed/26160525
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1038/eye.2015.104
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars